drugset / Trial / NCT01292993

A Study to Evaluate the Interaction of LX4211 and Metformin in Healthy Subjects

NCT01292993

Phase 1 Completed 18 enrolled Lexicon Pharmaceuticals
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine the effects of LX4211 and metformin on each other when given at the same time as single doses to healthy human subjects.

Timeline

Start
2011-02
Primary completion
2011-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1000 mg Oral
Subject Sotagliflozin Small molecule 400 mg Oral